Outcome of the Board meeting dated July 24 2026 for the approval of the unaudited financial results (Standalone and Consolidated) for the quarter ended June 30 2026.
24-Jul-2026
Download PDF
Onesource Specialty Pharma
Outcome of the Board meeting dated July 24 2026 for the approval of the unaudited financial results (Standalone and Consolidated) for the quarter ended June 30 2026.